ORKA-001

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Dose Ranging Study of ORKA-001 in Patients With Moderate-to-Severe Plaque PsoriasisNCT07290569ORKAPhase 2Active not recruiting2026-10-21Actual
An Open-Label Extension Study of ORKA-001 in Participants With Plaque PsoriasisNCT07449702ORKAPhase 2Recruiting2030-05Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.